Sign in
8-K

Current Report

Theriva Biologics, Inc. Filed Acc 0001104659-20-140976

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading tm2039650d1_8k.htm…